Topic Review
The Efficacy of Spirulina Supplementation on Diabetes
As a result of rising mortality rates due to cardiovascular diseases (CVDs), there has been a growing urgency to find alternative approaches to conventional pharmaceutical treatment to prevent the onset of chronic diseases. Arthrospira platensis, commonly known as Spirulina, is a blue-green cyanobacterium, classified as a “superfood”, used worldwide as a nutraceutical food supplement due to its remarkable nutritional value, lack of toxicity, and therapeutic effects. Many research studies have demonstrated that Spirulina has therapeutic functions such as antioxidant, anti-inflammatory, hypolipidemic, antidiabetic, and brain-protective properties.
  • 107
  • 29 Feb 2024
Topic Review
Precision Nutrition in Obesity Management
Obesity is a complex metabolic disorder that is associated with several diseases. Precision nutrition (PN) has emerged as a tailored approach to provide individualised dietary recommendations. 
  • 44
  • 28 Feb 2024
Topic Review
Diet and Lipid-Lowering Nutraceuticals in Familial Hypercholesterolemia
Familial hypercholesterolemia is a genetically determined disease characterized by elevated plasma total and LDL cholesterol levels from the very first years of life, leading to early atherosclerosis. Nutritional intervention is the first-line treatment, complemented with nutraceuticals and drug therapy when necessary.
  • 57
  • 27 Feb 2024
Topic Review
Pathophysiological Mechanism of Cognitive Impairment in Obese Persons
Cognition is a global concept encompassing various processes virtually scattered over the whole brain. Obesity itself can be viewed as a consequence of impaired energetic feedback loops or as a higher disorder of impaired reward—behavior control mechanisms. However, the adipose tissue—brain relation is much more than a simple direct bilateral communication involving virtually all metabolically active organs and a plethora of messengers.
  • 70
  • 26 Feb 2024
Topic Review
Glycemic Index/Glycemic Load in Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is a common metabolic disorder that often develops during pregnancy, characterized by glucose intolerance and insulin resistance (IR). To ensure the well-being of both the mother and the fetus, the body undergoes multiple metabolic and immunological changes that result in peripheral IR and, under certain hereditary or acquired abnormalities, GDM in predisposed women. The adverse short- and long-term effects of GDM impact both the mother and the fetus. Nutrition seems to play an important role to prevent GDM or improve its evolution. An emphasis has been given to the proportion of carbohydrates (CHO) relative to protein and lipids, as well as dietary patterns, in GDM. The effects of CHO on postprandial glucose concentrations are reflected in the glycemic index (GI) and glycemic load (GL). Diets rich in GI and GL may induce or exacerbate IR, whereas diets low in GI and GL appear to enhance insulin sensitivity and improve glycemic control. These positive outcomes may be attributed to direct interactions with insulin and glucose homeostasis or indirect effects through improved body composition and weight management. 
  • 149
  • 23 Feb 2024
Topic Review
SGLT-2 Inhibitors in Diabetes Mellitus Therapy
The primary treatment for autoimmune Diabetes Mellitus (Type 1 Diabetes Mellitus-T1DM) is insulin therapy. Unfortunately, a multitude of clinical cases has demonstrated that the use of insulin as a sole therapeutic intervention fails to address all issues comprehensively. Therefore, non-insulin adjunct treatment has been investigated and shown successful results in clinical trials. Various hypoglycemia-inducing drugs such as Metformin, glucagon-like peptide 1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, amylin analogs, and Sodium-Glucose Cotransporters 2 (SGLT-2) inhibitors, developed good outcomes in patients with T1DM. SGLT-2 inhibitors have remarkably improved the treatment of patients with diabetes by preventing cardiovascular events, heart failure hospitalization, and progression of renal disease. However, their pharmacological potential has not been explored enough. 
  • 444
  • 23 Feb 2024
Topic Review
Different Vitamin D Compounds in Adiposity
A large body of research shows an association between higher body weight and low vitamin D status, as assessed using serum 25-hydroxyvitamin D concentrations. Vitamin D can be metabolised in adipose tissue and has been reported to influence gene expression and modulate inflammation and adipose tissue metabolism in vitro. However, the exact metabolism of vitamin D in adipose tissue is currently unknown. White adipose tissue expresses the vitamin D receptor and hydroxylase enzymes, substantially involved in vitamin D metabolism and efficacy. The distribution and concentrations of the generated vitamin D compounds in adipose tissue, however, are largely unknown. Closing this knowledge gap could help to understand whether the different vitamin D compounds have specific health effects in the setting of adiposity. 
  • 49
  • 23 Feb 2024
Topic Review
Potential Beneficial Effects of Dietary Supplements against COVID-19
Diet and dietary supplements aim to add trace elements, vitamins, and minerals to the body to improve human health and boost the immune system. In the peculiar circumstances of the COVID-19 pandemic, in combination with disease prevention techniques, the strengthening of the immune system is considered particularly important to enable it to effectively respond to and eliminate the SARS-CoV-2 viral pathogen in the event of infection. 
  • 70
  • 21 Feb 2024
Topic Review
Caenorhabditis elegans for Screening Probiotics with Antiobesity Properties
Due to the role of gut microbiota in the regulation of lipid, glucose, and insulin homeostasis, probiotics with beneficial properties have emerged as an alternative therapeutic tool to ameliorate metabolic diseases-related disturbances, including fat excess or inflammation. Different strains of bacteria, mainly lactic acid bacteria (LAB) and species from the genus Bifidobacterium, have emerged as potential probiotics due to their anti-obesogenic and/or anti-diabetic properties. However, in vivo studies are needed to demonstrate the mechanisms involved in these probiotic features. In this context, Caenorhabditis elegans has emerged as a very powerful simple in vivo model to study the physiological and molecular effects of probiotics with potential applications regarding the different pathologies of metabolic syndrome.
  • 61
  • 18 Feb 2024
Topic Review
Dietary Intervention for Lipoprotein(a) Levels
Lipoprotein(Lp)(a) is a variant of low-density lipoprotein (LDL), bound to apolipoprotein B100, whose levels are associated with a significant increase in the risk of atherosclerosis-related cardiovascular events, but also to aortic stenosis and atrial fibrillation.
  • 53
  • 18 Feb 2024
  • Page
  • of
  • 79